DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Perry J. et al.
The temozolomide RESCUE study: A phase II trial of continuous (28/28) dose-intense temozolomide (TMZ) after progression on conventional 5/28 day TMZ in patients with recurrent malignant glioma.
J Clin Oncol 2008;
26: S15. abstr 2010.
We do not assume any responsibility for the contents of the web pages of other providers.